Ting Luo

3PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 24, 2024
Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.

Lan Chen, Xi Yan, Ting Luo

|Apr 20, 2023
Optimum duration of extended adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: protocol for a network meta-analysis of randomised controlled trials.

Qiancheng Hu, Daoli Ye, Zhao Xudong

|May 31, 2022
Role of CDK4/6 inhibitors in patients with hormone receptor (HR)-positive, human epidermal receptor-2 negative (HER-2) metastatic breast cancer study protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.

Qiancheng Hu, Wenli Kang, Qingfeng Wang

Pageof 1

Frequent Collaborators

1 joint publications

Hongfeng Gou

1 joint publications

Lan Chen